Evofem Biosciences, Inc. (EVFM) stock
EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-10.00%)
Close on Oct 19, 2026Market cap $865.23KP/E –Yield –
Evofem Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Evofem Biosciences's enterprise value was $911.94K on Oct 19, 2026, against $765.20K a year earlier. Over the last 5 years it ranged from -$11.27M to $64.90M, with a median of $392.46K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $911.94K | +45.1% |
| 2025 | Dec 31, 2025 | $628.59K | +16.6% |
| 2024 | Dec 31, 2024 | $539.25K | – |
| 2023 | Dec 29, 2023 | -$474.45K | – |
| 2022 | Dec 30, 2022 | -$1.22M | -102.8% |
| 2021 | Dec 31, 2021 | $43.46M | -60.2% |
| 2020 | Dec 31, 2020 | $109.18M | -57.4% |
| 2019 | Dec 31, 2019 | $256.58M | +166.2% |
| 2018 | Dec 31, 2018 | $96.38M | +313.6% |
| 2017 | Dec 29, 2017 | $23.30M | +1977.7% |
| 2016 | Dec 30, 2016 | $1.12M | – |
| 2015 | Dec 31, 2015 | -$22.32M | – |
| 2014 | Dec 31, 2014 | -$493.11K | – |
See a number that looks wrong?